Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Overall deregulation in gene expression as a novel indicator of tumor aggressiveness in colorectal cancer

Abstract

Malignant transformation of the cell is accompanied and characterized by disruption of genetic material and aberrant expression of multiple genes. Systematic analysis of differential gene expression in human tumor samples may provide an estimate of the degree of genetic and epigenetic deregulation in neoplastic cells. We have assessed, by means of a RNA differential display technique, the overall gene expression deregulation in a prospectively collected series of 68 human colorectal carcinomas. An index of differential expression has been calculated for each case. A similar proportion of the displayed sequences (23%) was under- and over-represented in the tumor in respect of the normal tissue. An increased variation in the expression profile was observed in advanced Dukes' stages (P<0.02) and correlated with lymph node invasion (P<0.05). Furthermore, a diminished overall survival was associated to increased rates of deregulation (Log-rank, P<0.02) and especially down-regulation (P<0.001). When Cox multivariate analysis was performed in front of Dukes' stage, both indexes of differential expression were independent indicators of a worse outcome (P=0.05 and P<0.01 respectively). We conclude that estimation of the fraction of differentially displayed tags by RNA fingerprinting may have relevant applications in the prognostic assessment of colorectal cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Arribas R, Capella G, Tórtola S, Masramon L, Grizzle WE, Perucho M and Peinado MA. . 1997 J. Clin. Oncol. 15: 3230–3240.

  • Baylin SB. . 1997 Science 277: 1948–1949.

  • Bird AP. . 1986 Nature 321: 209–213.

  • Delattre O, Law DJ, Remvikos Y, Sastre X, Feinberg AP, Olschwang S, Melot T, Salmon RJ and Validire P. . 1989 Lancet 11: 353–355.

  • Dutrillaux B. . 1995 Adv. Cancer Res. 67: 59–82.

  • Friedberg EC. . (1996). Relationships between DNA repair and transcription Ann. Rev. Biochem. 65: 15–42.

  • Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M. . 1993 Nature 363: 558–561.

  • Jones PA and Gonzalgo ML. . 1997 Proc. Natl. Acad. Sci. USA 94: 2103–2105.

  • Kern SE, Fearon ER, Tersmette KWF, Enterline JP, Leppert M, Nakamura Y, White R, Vogelstein B and Hamilton SR. . 1989 JAMA 261: 3099–3103.

  • Kim H, Jen J, Vogelstein B and Hamilton SR. . 1994 Am. J. Pathol. 145: 148–156.

  • Kokal W, Sheibani K, Terz J and Harada JR. . 1986 JAMA 255: 3123–3127.

  • Lengauer C, Kinzler KW and Vogelstein B. . 1997 Proc. Natl. Acad. Sci. USA 94: 2545–2550.

  • Liang P and Pardee AB. . 1992 Science 257: 967–971.

  • Ricote M, Geller P and Perucho M. . 1997 Mutat. Res. 374: 153–167.

  • Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, Heselmeyer K, du Manoir S and Auer G. . 1996 Genes Chrom. Cancer 15: 234–245.

  • Sager R. . 1997 Proc. Natl. Acad. Sci. USA 94: 952–955.

  • Schlegel J, Stumm G, Scherthan H, Bocker T, Zirngibl H, Ruschoff J and Hofstadter F. . 1995 Cancer Res. 55: 6002–6005.

  • Scicchitano DA and Mellon I. . 1997 Environ. Health Perspect. 105: (Suppl 1) 145–153.

  • Thein SL, Jeffreys AJ, Gooi HC, Cotter F, Flint J, O'Connor NTJ, Weatherall DJ and Wainscoat JS. . 1987 Br. J. Cancer 55: 353–356.

  • Thibodeau SN, Bren G and Schaid D. . 1993 Science 260: 816–819.

  • Thomas JH. . 1995 Proc. Natl. Acad. Sci. USA 92: 480–482.

  • Tórtola S, Capella G, Marcuello E, Günter K, Aiza G, Masramon L, Reymond MA and Peinado MA. . 1998 Lab. Invest. 78: 309–317.

  • Versteeg R. . 1997 Am. J. Hum. Genet. 60: 751–754.

  • Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM and Bos JS. . 1988 N. Engl. J. Med. 319: 525–532.

  • Welsh J, Chada K, Dalal SS, Cheng R, Ralph D and McClelland M. . 1992 Nucleic Acids Res. 20: 4965–4970.

Download references

Acknowledgements

We thank Marta Pujol and Maria Julià for technical support, and Victor Moreno for help in the statistical analysis. This work was supported by grants from Comisión Interministerial de Ciencia y Tecnología (CICYT), Fundació La Marató de TV3 and Fondo de Investigación Sanitaria (FIS). S Tórtola was a fellow of the Spanish Ministry of Education. R A Risques was a fellow of Comissió Interdepartamental de Recerca i Innovació Tecnològica (CIRIT).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tórtola, S., Marcuello, E., Risques, RA. et al. Overall deregulation in gene expression as a novel indicator of tumor aggressiveness in colorectal cancer. Oncogene 18, 4383–4387 (1999). https://doi.org/10.1038/sj.onc.1202757

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202757

Keywords

This article is cited by

Search

Quick links